Search research articles
Contact Us
Filters
Showing results (371-380 of 411) with videos related to
Page
of 42
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2023
Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study
Georg C Lodde, Jessica Hassel, Lena M Wulfken, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2026
Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG
Konstantinos Lallas, Lena Nanz, Selma Ugurel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2026
Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study
Lea Jessica Albrecht, Jana Garnier, Anne Zaremba, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2025
Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma
Viola K DeTemple, Martin Kaatz, Eggert Stockfleth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 11, 2017
Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma
Markus V Heppt, Alexander Roesch, Benjamin Weide, et al.
Science (New York, N.Y.)
|
September 12, 2015
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M Van Allen, Diana Miao, Bastian Schilling, et al.
Journal of Clinical Medicine
|
May 16, 2020
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial
Theresa Steeb, Anja Wessely, Dagmar von Bubnoff, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2017
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition
Markus V Heppt, Lucie Heinzerling, Katharina C Kähler, et al.
Journal for Immunotherapy of Cancer
|
October 23, 2020
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients
Ulrike Leiter, Carmen Loquai, Lydia Reinhardt, et al.
The Journal of Investigative Dermatology
|
April 19, 2020
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma
Maya Farah, Alexandre Reuben, Ivelina Spassova, et al.
Page
of 42
Search research articles
Search
Showing results (371-380 of 411) with videos related to
Sort By:
Page
of 42
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2023
Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study
Georg C Lodde, Jessica Hassel, Lena M Wulfken, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2026
Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG
Konstantinos Lallas, Lena Nanz, Selma Ugurel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2026
Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study
Lea Jessica Albrecht, Jana Garnier, Anne Zaremba, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2025
Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma
Viola K DeTemple, Martin Kaatz, Eggert Stockfleth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 11, 2017
Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma
Markus V Heppt, Alexander Roesch, Benjamin Weide, et al.
Science (New York, N.Y.)
|
September 12, 2015
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M Van Allen, Diana Miao, Bastian Schilling, et al.
Journal of Clinical Medicine
|
May 16, 2020
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial
Theresa Steeb, Anja Wessely, Dagmar von Bubnoff, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2017
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition
Markus V Heppt, Lucie Heinzerling, Katharina C Kähler, et al.
Journal for Immunotherapy of Cancer
|
October 23, 2020
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients
Ulrike Leiter, Carmen Loquai, Lydia Reinhardt, et al.
The Journal of Investigative Dermatology
|
April 19, 2020
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma
Maya Farah, Alexandre Reuben, Ivelina Spassova, et al.
Page
of 42